BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35689211)

  • 1. KCNN4 may weaken anti-tumor immune response via raising Tregs and diminishing resting mast cells in clear cell renal cell carcinoma.
    Cui Y; Shen T; Xu F; Zhang J; Wang Y; Wu J; Bu H; Fu D; Fang B; Lv H; Wang S; Shi C; Liu B; He H; Tang H; Ge J
    Cancer Cell Int; 2022 Jun; 22(1):211. PubMed ID: 35689211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Novel Prognostic Signatures for Clear Cell Renal Cell Carcinoma Based on ceRNA Network Construction and Immune Infiltration Analysis.
    Zhou L; Ye J; Wen F; Yu H
    Dis Markers; 2022; 2022():4033583. PubMed ID: 35320950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Construction and Analysis of ceRNA Network and Immune Infiltration in Kidney Renal Clear Cell Carcinoma.
    Deng L; Wang P; Qu Z; Liu N
    Front Genet; 2021; 12():667610. PubMed ID: 34567057
    [No Abstract]   [Full Text] [Related]  

  • 4. A construction and comprehensive analysis of ceRNA networks and infiltrating immune cells in papillary renal cell carcinoma.
    Fan Y; Dai F; Yuan M; Wang F; Wu N; Xu M; Bai Y; Liu Y
    Cancer Med; 2021 Nov; 10(22):8192-8209. PubMed ID: 34598322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of ceRNA networks to determine genes related to prognosis, overall survival, and immune infiltration in clear cell renal carcinoma.
    Chalbatani GM; Momeni SA; Mohammadi Hadloo MH; Karimi Z; Hadizadeh M; Jalali SA; Miri SR; Memari F; Hamblin MR
    Comput Biol Med; 2022 Feb; 141():105043. PubMed ID: 34839901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of the MIR4435-2HG/miR-1-3p/MMP9/miR-29-3p/DUXAP8 ceRNA network axis in hepatocellular carcinoma.
    Zhang L; Hu S; Chen J; Ma S; Liu F; Liu C; Gao Y
    Discov Oncol; 2021 Oct; 12(1):38. PubMed ID: 35201491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ceRNA network development and tumor-infiltrating immune cell analysis in hepatocellular carcinoma.
    Chen L; Zou W; Zhang L; Shi H; Li Z; Ni C
    Med Oncol; 2021 Jun; 38(7):85. PubMed ID: 34148185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KCNN4 is a potential prognostic marker and critical factor affecting the immune status of the tumor microenvironment in kidney renal clear cell carcinoma.
    Chen S; Wang C; Su X; Dai X; Li S; Mo Z
    Transl Androl Urol; 2021 Jun; 10(6):2454-2470. PubMed ID: 34295732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and analysis of a ceRNA network and patterns of immune infiltration in bladder cancer.
    Fu Y; Sun S; Bi J; Kong C; Yin L
    Transl Androl Urol; 2021 May; 10(5):1939-1955. PubMed ID: 34159075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The construction and analysis of tumor-infiltrating immune cell and ceRNA networks in recurrent soft tissue sarcoma.
    Huang R; Meng T; Chen R; Yan P; Zhang J; Hu P; Zhu X; Yin H; Song D; Huang Z
    Aging (Albany NY); 2019 Nov; 11(22):10116-10143. PubMed ID: 31739284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.
    Tan J; Wang W; Song B; Song Y; Meng Z
    Biomed Res Int; 2020; 2020():2837906. PubMed ID: 32802839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome Instability and Long Noncoding RNA Reveal Biomarkers for Immunotherapy and Prognosis and Novel Competing Endogenous RNA Mechanism in Colon Adenocarcinoma.
    Ren Z; Wang Z; Gu D; Ma H; Zhu Y; Cai M; Zhang J
    Front Cell Dev Biol; 2021; 9():740455. PubMed ID: 34746134
    [No Abstract]   [Full Text] [Related]  

  • 13. The construction and analysis of tumor-infiltrating immune cells and ceRNA networks in metastatic adrenal cortical carcinoma.
    Huang R; Liu Z; Tian T; Song D; Yan P; Yin H; Hu P; Zhu X; Liu Y; Li Z; Meng T; Zhang J; Huang Z
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32175564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Construction and Analysis of Tumor-Infiltrating Immune Cells and ceRNA Networks in Bladder Cancer.
    Jiang A; Liu N; Bai S; Wang J; Gao H; Zheng X; Fu X; Ren M; Zhang X; Tian T; Ruan Z; Yao Y; Liang X
    Front Genet; 2020; 11():605767. PubMed ID: 33391354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MMP25-AS1/hsa-miR-10a-5p/SERPINE1 axis as a novel prognostic biomarker associated with immune cell infiltration in KIRC.
    Tan P; Chen H; Huang Z; Huang M; Du Y; Li T; Chen Z; Liu Y; Fu W
    Mol Ther Oncolytics; 2021 Sep; 22():307-325. PubMed ID: 34553021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hub Long Noncoding RNAs with m6A Modification for Signatures and Prognostic Values in Kidney Renal Clear Cell Carcinoma.
    Lin G; Wang H; Wu Y; Wang K; Li G
    Front Mol Biosci; 2021; 8():682471. PubMed ID: 34295922
    [No Abstract]   [Full Text] [Related]  

  • 17. The Construction and Analysis of ceRNA Network and Patterns of Immune Infiltration in Mesothelioma With Bone Metastasis.
    Huang R; Wu J; Zheng Z; Wang G; Song D; Yan P; Yin H; Hu P; Zhu X; Wang H; Lv Q; Meng T; Huang Z; Zhang J
    Front Bioeng Biotechnol; 2019; 7():257. PubMed ID: 31681739
    [No Abstract]   [Full Text] [Related]  

  • 18. COLGALT1 is a potential biomarker for predicting prognosis and immune responses for kidney renal clear cell carcinoma and its mechanisms of ceRNA networks.
    Liu S; Yu Y; Wang Y; Zhu B; Han B
    Eur J Med Res; 2022 Jul; 27(1):122. PubMed ID: 35842702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of Competitive Endogenous RNA Network and Verification of 3-Key LncRNA Signature Associated With Distant Metastasis and Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.
    Su Y; Zhang T; Tang J; Zhang L; Fan S; Zhou J; Liang C
    Front Oncol; 2021; 11():640150. PubMed ID: 33869028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a three-long noncoding RNA prognostic model involved competitive endogenous RNA in kidney renal clear cell carcinoma.
    Zhang D; Zeng S; Hu X
    Cancer Cell Int; 2020; 20():319. PubMed ID: 32694941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.